|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-5-27
|
|
pubmed:abstractText |
Insulin Mix25 is a new premixed insulin analog containing 25% insulin lispro and 75% neutral protamine lispro (NPL) suspension (NPL insulin). The aim of the study was to compare serum glucose and insulin responses after breakfast in type 2 diabetic patients who received Mix25, premixed regular/NPH (30%/70%), or NPH insulin before the meal.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
459-62
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10097929-Blood Glucose,
pubmed-meshheading:10097929-Diabetes Mellitus, Type 2,
pubmed-meshheading:10097929-Double-Blind Method,
pubmed-meshheading:10097929-Eating,
pubmed-meshheading:10097929-Fasting,
pubmed-meshheading:10097929-Female,
pubmed-meshheading:10097929-Humans,
pubmed-meshheading:10097929-Hypoglycemic Agents,
pubmed-meshheading:10097929-Insulin,
pubmed-meshheading:10097929-Insulin, Isophane,
pubmed-meshheading:10097929-Insulin Lispro,
pubmed-meshheading:10097929-Male,
pubmed-meshheading:10097929-Middle Aged,
pubmed-meshheading:10097929-Osmolar Concentration,
pubmed-meshheading:10097929-Reference Values
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.
|
|
pubmed:affiliation |
Department of Medicine, Helsinki University Hospital, Finland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
